76 results about "Phosphodiester bond" patented technology

Compositions and methods for modulating the activity of RNA and DNA are disclosed. In accordance with preferred embodiments, antisense compositions are prepared comprising targeting and reactive portions. Reactive portions which act, alternatively, through phosphorodiester bond cleavage, through backbone sugar bond cleavage or through base modification are preferrably employed. Groups which improve the pharmacodynamic and pharmacokinetic properties of the oligonucleotides are also useful in accordance with certain embodiments of this invention. Delivery of the reactive or non-reactive functionalities into the minor groove formed by the hybridization of the composition with the target RNA is also preferrably accomplished. Therapeutics, diagnostics and research methods and also disclosed. Synthetic nucleosides and nucleoside fragments are also provided useful for elaboration of oligonucleotides and oligonucleotide analogs for such purposes.

Compositions and methods are provided for the modulation of expression of the human ras gene in both the normal and activated forms. Oligonucleotides are provided that have methylene(methylimino) linkages alternating with phosphorothioate or phosphodiester linkages. Further oligonucleotides are provide that have a first region having a methylene(methylimino) linkage alternating with a phosphorothioate or phosphodiester linkage and a second region having phosphorothioate linkages. Such oligonucleotides can be used for diagnostics as well as for research purposes including methods for diagnosis, detection and treatment of conditions arising from the activation of the H-ras gene.

The invention provides methods for synthesizing oligonucleotides using nucleoside monomers having carbonate protected hydroxyl groups that are deprotected with α-effect nucleophiles. The α-effect nucleophile irreversibly cleave the carbonate protecting groups while simultaneously oxidizing the internucleotide phosphite triester linkage to a phosphodiester linkage. The procedure may be carried out in aqueous solution at neutral to mildly basic pH. The method eliminates the need for separate deprotection and oxidation steps, and, since the use of acid to remove protecting groups is unnecessary, acid-induced depurination is avoided. Fluorescent or other readily detectable carbonate protecting groups can be used, enabling monitoring of individual reaction steps during oligonucleotide synthesis. The invention is particularly useful in the highly parallel, microscale synthesis of oligonucleotides.

Provided are sequencing-by-binding methods of detecting cognate nucleotides using a crippled DNA polymerizing enzyme that possesses the ability to bind the next correct nucleotide downstream of a primer in a template-dependent fashion, but does not possess the activity needed to promote phosphodiester bond formation. Use of the crippled DNA polymerase permits interrogation of one nucleotide at a time, without incorporation of any nucleotide. Labeled nucleotides, such as fluorescently labeled nucleotides, can be used in conjunction with the crippled DNA polymerase to establish cognate nucleotide identity in a rapid manner.

The present invention provides a chain-shortened polynucleotide wherein the proportion of a 2'-5' phosphodiester bond is up to 3% based on the whole phosphodiester bonds or a salt thereof and a pharmaceutical composition containing the same, and a method for producing the same.

An fibrous insulation product is provided that includes a binder comprising a polyol and a phosphorus crosslinking agent derived from a phosphonic or phosphoric acid, salt, ester or anhydride to form crosslinked phosphodiester linkages. The polyol is polyvalent, but may be monomeric or preferably polymeric; and may be synthetic or natural in origin. Carbohydrate polysaccharides are exemplary polyols, including water-soluble polysaccharides such as dextrin, maltodextrin, starch, modified starch, etc. Additionally, the carbohydrate polymer may have a dextrose equivalent (DE) number from 2 to 20. In exemplary embodiments, the binder may also include a catalyst, a coupling agent, a process aid, and other additives. The environmentally friendly, formaldehyde-free binder may be used in the formation of residential and commercial insulation materials and non-woven chopped strand mats. A method of making fibrous products is also provided.

The invention provides methods and compositions for improving the fidelity of a sequencing-by-synthesis reaction by using a nucleotide derivative that forms a hydrogen bond with a complementary nucleotide on a template, but fails to form a phosphodiester bond with the 3′ hydroxyl group of a primer under conditions otherwise suitable for a polymerization reaction; thereby blocking incorporation of a mismatched nucleotide.

The invention provides a method of nonenzymatic ligation of a nucleic acid. The method consists of contacting a polynucleotide-3′ phosphorothiolate with an acceptor polynucleotide under conditions that allow formation of a phosphodiester bond between the polynucleotide-3′ phosphorothiolate and the acceptor polynucleotide. The invention also provides methods of molecular cloning. In one embodiment, the method consists of contacting an insert comprising a polynucleotide-3′ phosphorothiolate with an acceptor vector under conditions that allow formation of a phosphodiester bond between the insert and the acceptor vector to generate a vector comprising an insert polynucleotide. The invention further provides a compound consisting of a polynucleotide-3′ phosphorothiolate and a kit containing a polynucleotide-3′ phosphorothiolate. Also provided is a method of ligating a nucleic acid using a non-sequence specific topoisomerase.

The invention provides the artificial inner cut enzyme which can cut phosphodiester bond in nucleic acid selectivitily. The inner cut enzyme contains recognition and cutting details. The recognition details is single strand of peptide nucleic acid which constitutional unit is 6-200 qae glycine. The cutting details is chelating agent of rare earth metal ion which is chelated with metal ion at the ammonia or carbon terminal of single strand of peptide nucleic acid and which has joint between the chelating agent and single strand. the artificial inner cut enzyme can be used implemental enzyme widely in molecular biology, genetic engineering and medical treatment area.

The invention discloses an iodine dissociation type gene cloning method based on sulfo-modifiers. According to the method, phosphodiester bonds between the positions of 1-15, 16, 17, 18, 19 or 20 of the 5' ends of primers of a target gene and a plasmid vector are amplified into the sulfo-modifiers; a base sequence at the positions of 1-15, 16, 17, 18, 19 or 20 of the 5' ends of forward primers of the target gene and the plasmid vector and a base sequence at the positions of 1-15, 16, 17, 18, 19 or 20 of the 5' ends of reverse primers of the target gene and the plasmid vector are matched in a supplementary mode; after the target gene and the plasmid vector are subjected to PCR amplification, a PCR product is purified; iodine selectively breaks the phosphodiester bonds of the sulfo-modifiers, and under the combined action of existence of the sulfo-modifiers at the positions of 1-15, 16, 17, 18, 19 or 20 of the 5' ends and iodine heat treatment, DNA will generate a 3' single-link protruding end where 20 nucleotides grow. Through the method, cloning of the target gene does not rely on restriction endonuclease, DNA ligase or any other DNA modification enzyme, operation flux is large, and the method can be applied to large-scale gene cloning.

A variety of T4DNA ligase mutants that exhibit enhanced ligation activity at high salt concentrations as compared to wild-type ligases are engineered, characterized and selected via gel electrophoresis of ligation products from standard ligation assays. A ligase catalyzes the formation of a phosphodiester bond between the 5'end and the 3 'end of complementary cohesive or blunt ends of double helix DNA, which process is crucial for many molecular biological processes, including cloning and sequencing.

The method provides a method for improving the specificity in a cutting position of endonuclease V and relates to a high-throughput method for analyzing DNA sequences, in particular to a high-speed low-cost and high-throughput method for DNA sequencing. Recognition-site deoxyinosine dI containing the endonuclease V and DNA segments of single-chain oligonucleotide at a site where oxygen on one or more phosphodiester bonds in a DNA chain is sulfo-modified are introduced into a DNA probe, and the distance between the recognition site of the endonuclease V and the sulfo-modified site is two or more basic groups. The method can be used for analyzing unknown DNA, namely sequence information of a template DNA to be analyzed. Re-hybridized high-throughput primers are obtained by synthesis and purification by a very mature solid-phase DNA method, and therefore, the method does not have wrongly extended accumulative effect and can maintain the amount of DNA templates and sequencing primers. The determination of the sequence is correct and reliable, having no limitations on sequenced length.

An object of the present invention is to provide a highly stable nucleic acid-polysaccharide complex of an siRNA and schizophyllan. A nucleic acid-polysaccharide complex is formed by adding polydeoxyadenine in which at least part of the phosphodiester link portion is phosphorothioated to an siRNA and allowing the siRNA and schizophyllan to form a complex.

Provided is an immunostimulating oligonucleotide that is suitable for industrial production and has an excellent type-I IFN inducing activity even when not modified to become a phosphorothioate. This linear double-stranded oligonucleotide contains 10-100 base pairs, wherein the single-stranded oligonucleotides constituting the double-stranded oligonucleotide each contain 2-20 phosphodiester-mediated cytosine-guanine (CpG) sequences, and at least 90% of the internucleotide bonds in each single-stranded oligonucleotide are phosphodiester bonds.

The invention provides a determination method for the activity of phospholipase D alpha. The determination method for the activity of the phospholipase D alpha is a method for determining the activity of the phospholipase D alpha by using an enzyme-linked colorimetry. The technical scheme is that the determination method comprises the following steps: performing catalyzed hydrolysis on a phosphodiester bond at the tail end of phosphatidylcholine serving as a substrate by the phospholipase D alpha to generate phosphatidic acid and choline; enabling the choline to react to generate betaine and H2O2 under catalytic action of a choline oxidase; oxidizing 4-aminoantipyrine aspirin and redistilled phenol into a pink substance by the generated H2O2 under the catalytic action of peroxidase, determining the absorbance value of the pink substance, determining the corresponding choline content according to a choline standard curve which is prepared in advance, and deducing the activity of the phospholipase D alpha according to the choline content. In a reaction system with 200 microliters of the phospholipase D alpha, the protein content and the Ca<2+> concentration are preferably 10 microgramme and 10mM. The determination method is high in efficiency, convenient, quick, high in sensitivity, low in hazard and stable in results, and is suitable for simultaneously determining the activities of the phospholipase D alpha of a large number of samples.

In accordance with the present invention, there is provided a novel restriction endonuclease obtainable from Bacillus thermoglucosidasius 36A (NEB#1384), hereinafter referred to as “BtgZI”, which endonuclease:

(1) recognizes the nucleotide sequence 5′-GCGATG-3′ in a double-stranded DNA molecule as shown below,
 (wherein G represents guanine, C represents cytosine, A represents adenine, T represents thymine and N represents either G, C, A, or T); (2) cleaves said sequence in the phosphodiester bonds between the 10th and the 11th nucleotides 3′ to the recognition sequence in the 5′-GCGATG-3 strand of the DNA, and between the 14th and 15th nucleotides 5′ to the recognition sequence in the complement stand, 5′-CATCGC-3′, to produce a 4 base 5′ extension; and (3) cleaves double-stranded pBR322 DNA to produce 3 fragments of 2892, 1181 and 288 base pairs.

The invention belongs to the field of target drug design and preparation, and particularly relates to a prodrug with anti-tumor activity and preparation and application thereof. The prodrug is obtained by constructing biotin and a phosphoramidite monomer of gemcitabine on 10-100 base nucleic acid skeletons through a 3',5'-phosphodiester linkage, or by cross-linking biotin on a multi-carbon chain which has NH2 and is extended from 10-100 base nucleic acid skeletons containing gemcitabine through an amido linkage. The drug has better inhibition effect on tumor cells and has lower toxicity, and the in vitro cell transport of the prodrug does not depend on the expression of nucleic acid transport vector protein, thereby being beneficial to reducing the drug resistance of GEM; and the drug canmaintain higher drug concentration and half-life period in an organism, overcomes the problems of low anticancer target selectivity, easy deamination passivation and easy drug resistance of GEM, and achieves the effect of clearing cancer cells through target antagonism tumor metabolic pathways.